Stock listing

NASDAQ:CEGE Cell Genesys Inc Stock

Follow Cell Genesys Inc into a list and get an email when it puts out news.

Last close · NASDAQ:CEGE

$0.327 USD

Close on Oct 14, 2009 · No longer trades

Jan 4, 1999 to last close -94.3% · monthly closes, Jan 4, 1999 – Oct 14, 2009
Lowest – highest close
$0.102 – $52.000 USDSince Jan 4, 1999 · lowest Oct 24, 2008 · highest Mar 3, 2000

Delisted NASDAQ:CEGE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:CEGE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Cell Genesys Inc on 6ix

Decks
1 deck · latest Aug 7, 2009

Decks

DeckKindSlidesDate
Merger or Acquisition (August 2009)Merger or acquisition19 slidesAug 7, 2009

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Stephen A. Sherwin
Other companies: Biogen Inc. (Director · Since at least Mar 20, 2010); Neurocrine Biosciences, Inc. (Director · Since at least Jun 30, 2006); Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); BioPlus Acquisition Corp (Director · Dec 2, 2021 – Dec 2, 2021 · Past); Aduro Biotech Inc (Director · Jun 25, 2015 – May 5, 2020 · Past); Vical Incorporated (Director · May 23, 2013 – May 21, 2015 · Past); Verastem, Inc. (Director · Mar 5, 2013 – Jun 12, 2015 · Past); ANI Pharmaceuticals, Inc. (Director · Oct 14, 2009 – Mar 30, 2012 · Past); Rigel Pharmaceuticals, Inc. (Director · May 31, 2006 – May 11, 2016 · Past)
Chairman and CEO, Director · Feb 7, 2006 – Oct 14, 2009 · Past

Open People

Log in to ask 6ix AI your own questions about Cell Genesys Inc.